Shares of Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $0.96 and traded as low as $0.89. Quantum-Si shares last traded at $0.9090, with a volume of 7,800,436 shares changing hands.
Analyst Ratings Changes
QSI has been the subject of several recent analyst reports. Wall Street Zen raised Quantum-Si from a “sell” rating to a “hold” rating in a research note on Tuesday, October 27th. UBS Group restated a “buy” rating on shares of Quantum-Si in a research report on Thursday, November 12th. HC Wainwright reaffirmed a “buy” rating on shares of Quantum-Si in a research note on Thursday, November 12th. Weiss Ratings upgraded Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 24th. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.50.
Get Our Latest Report on Quantum-Si
Quantum-Si Trading Down 15.0%
The company has a market cap of $199.75 million, a price-to-earnings ratio of -2.33 and a beta of 3.26. The firm’s fifty day simple moving average is $1.17 and its 200 day simple moving average is $0.96.
Quantum-Si (NASDAQ:QSI – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 44.72% and a negative net margin of 6,729.80%. The company had revenue of $0.21 million for the quarter, compared to analysts’ expectations of $0.27 million. As a group, sell-side analysts expect that Quantum-Si Incorporated will post -0.42 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Knollwood Investment Advisory LLC purchased a new stake in Quantum-Si in the third quarter valued at approximately $321,000. Goldman Sachs Group Inc. purchased a new position in shares of Quantum-Si during the third quarter worth approximately $274,000. Empowered Funds LLC purchased a new position in shares of Quantum-Si during the third quarter worth approximately $210,000. Verdence Capital Advisors LLC purchased a new position in shares of Quantum-Si during the third quarter worth approximately $143,000. Finally, Renaissance Technologies LLC purchased a new position in shares of Quantum-Si during the first quarter worth approximately $91,000. Institutional investors and hedge funds own 39.90% of the company’s stock.
About Quantum-Si
Quantum-Si is a life sciences technology company developing tools for protein sequencing and proteomics research. Its platform uses semiconductor technology and single-molecule detection to analyze proteins, with the aim of making protein-level information more accessible to researchers. The company’s offerings include the Platinum benchtop instrument, along with consumables, reagents and software used to prepare, run and analyze samples. Quantum-Si’s products are designed for research applications in areas such as drug discovery and biological research.
Further Reading
- Five stocks we like better than Quantum-Si
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
